Choose a distance that'll make a difference and help us fund vital research to benefit everyone with cystic fibrosis.
The European Commission has formally approved the triple-combination therapy Kaftrio. Find out how it could help to treat people with cystic fibrosis.
Find all of our information and support available around coronavirus (COVID-19), including financial, health and shielding advice, in one place.
We're the largest charity funder of cystic fibrosis research in the UK. Explore some of our recent achievements, made possible by our supporters...
Following formal licensing by the European Commission, clinicians across the UK can now start prescribing the triple combination therapy Kaftrio to eligible people with cystic fibrosis.
Sign up to our e-newsletter to hear the latest news on what the Trust and its supporters are doing to fight for a life unlimited.
Choose a challenge that’s right for you and be a superhero at your own pace while raising as much money as you can for the Cystic Fibrosis Trust.
With the coronavirus (COVID-19) outbreak, lockdown and shielding, this year has undoubtedly been different. However, despite these hard times, the cystic fibrosis (CF) community continues to amaze us with their positivity, perseverance and dedication to our fight for a life unlimited by cystic fibrosis. To mark the end of summer, we recap some of this year’s imaginative fundraising events and extend an enormous thank to everyone who has supported us.
We invest more money into cystic fibrosis research than any other UK organisation.
Find out more about our vision for a life unlimited by cystic fibrosis for everyone with the condition, and our strategy for getting there.
If you have a question, query, comment or suggestion, we'd love to hear from you.
Discover answers to frequently asked questions about cystic fibrosis.